Pfizer Inc. is reportedly working on a deal that could finally satisfy investors’ cravings for a big acquisition. Last night, the Wall Street Journal reportedthat the pharma company is in very early talks to acquire Seagen Inc. for more than $30 billion, a deal that would instantly add four approved cancer drugs to its portfolio.
Pfizer isn’t Seagen’s first suitor. Merck & Co. spent much of last summer trying to iron out a deal with Seagen, one reportedly worth as much as $37 billion. But as Bloomberg first reported, talks stalled in late August as the companies ...
Read Full Story: https://news.google.com/rss/articles/CBMicmh0dHBzOi8vbmV3cy5ibG9vbWJlcmdsYXcu...
A La Habra-based provider of positron emission tomography scan services has agreed to pay more than $8.3 million to resolve allegations it violated the False Claims Act by offering improper payment...